|Articles|November 1, 2002

Applied Clinical Trials Supplements

Supplements-08-02-2002
Volume 0
Issue 0

Update 2002 IT Solutions Directory

Our 10th annual guide to applications highlights software, Web-based solutions, and more.

External Link - article-37090.pdf

Articles in this issue

almost 24 years ago

Article

Scaling up EDC: How to Move Away from Paper Trials

almost 24 years ago

Article

Supporting EDC in a Clinical Trial Environment

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

© putilov_denis - © putilov_denis - stock.adobe.com

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention

ByMarcela Roy, MA, Lauren Crooks, MSc, Graham Ellis, MD, Alan Kott, MUDR, Dawie Wessels, MD, Elias Ketiar, MD, MRCP

June 4th 2026

For pharmaceutical and life sciences organizations, the strategic imperative is clear: begin immediately with foundation building, scale systematically with measurable milestones, and transform comprehensively toward AI-native data operations. Credit: Stock.Adobe.com/tippapatt.

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

ByPartha Anbil,Partha Khot

June 4th 2026

SCOPE X: Why Sponsor-Specific Tech Is Still Holding Sites Back

ByLiz Beatty,Andy Studna, Senior Editor

June 4th 2026

ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease

ByAndy Studna, Senior Editor

June 4th 2026

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

BySam Hinsley,Andy Studna, Senior Editor

June 3rd 2026

Update 2002 IT Solutions Directory

Articles in this issue

Related Content

Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention

The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck

SCOPE X: Why Sponsor-Specific Tech Is Still Holding Sites Back

ACT Brief: AI-Driven Enrollment Results, Statistician Standards in Early Phase, and RNA Editing for Kidney Disease

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

Trending on Applied Clinical Trials Online

Why Real-World Evidence Can No Longer Wait Until After Approval

Three Tensions Transforming Clinical Operations Excellence

Getting the Foundation Right: Q&A with Sam Hinsley, Phastar

SCOPE X: The COPD Case Study That Shows What AI Can Do for Enrollment

ACT Brief: AI-Driven Patient Matching, Clinical Ops Tensions, and Oral COVID Prevention Approval